Valeant Pharmaceuticals International VP of Business Development Salaries in Albuquerque, NM
The average Valeant Pharmaceuticals International VP of Business Development in Albuquerque, NM earns an estimated $203,722 annually. Valeant Pharmaceuticals International's VP of Business Development compensation is $7,379 less than the US average for a VP of Business Development.
In Albuquerque, NM, The Business Development Department at Valeant Pharmaceuticals International earns $534 more on average than the Engineering Department.
Last updated 2 years ago.
- $203,722
- avg. base
VP of Business Development Salaries at Valeant Pharmaceuticals International
In Albuquerque, NM, VPs of Business Development earn $48,155 more than Business Development Managers, and $6,567 less than Directors of Business Development.
Compensation at Valeant Pharmaceuticals International by Department
In Albuquerque, NM, The Business Development Department averages $534 more than the Engineering Department, and $14,009 less than the Legal Department
VP of Business Development Compensation by Gender (All Companies)
The average female VP of Business Development at companies similar size to Valeant Pharmaceuticals International reported making $315,250, while the average male VP of Business Development at similar sized companies reported making $283,234.
VP of Business Development Compensation by Ethnicity (All Companies)
The average Caucasian VP of Business Development at companies similar size to Valeant Pharmaceuticals International reported making $304,764, while the average African American/Black VP of Business Development at similar sized companies reported making $140,000.
How VPs of Business Development at Valeant Pharmaceuticals International Rate Their Compensation
The majority of VPs of Business Development at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of VPs of Business Development at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
